Among those states that don’t cover the drugs, half reported that they are considering adding coverage in the near future. The 13 states where Medicaid covers GLP-1 drugs for obesity are California, ...
Hosted on MSN18m
Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey saysGLP-1s, or glucagon-like peptide-1 agonist drugs, are seemingly everywhere. In recent years, this class of weight-loss and Type 2 diabetes medication has become not only a household name but ...
The drugmaker’s total revenue from operations in the second quarter of current fiscal rose 16.5 per cent to ₹8,016 crore.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback